
Life is Our Passion.
Company.
We develop, produce and market cutting-edge technology for emergency and intensive care medicine to become a global leader for extracorporeal cardiopulmonary resuscitation.
We continuously bring new technologies to market that are precisely tailored to resuscitation in both settings, in- and out-of-hospital. Practice-oriented ongoing training and education prepare multi-professional teams optimally to apply CARL Technology.
We work together in an interdisciplinary manner with respect and appreciation to provide safe and high-quality patient care. We practice social responsibility, inclusion, and sustainability. Every day.
Opening a new chapter in the history of resuscitation.
Chronology.
The history of our company represents the successful implementation of a therapeutic vision.
2010


Founding of the company as a spin-off of Freiburg University Hospital on the initiative of Univ.-Prof. Dr. Dr. h. c. Friedhelm Beyersdorf, Former Medical Director of the Clinic of Cardiovascular Surgery at The Medical Center – University of Freiburg
2012


Development and optimization of the CARL Therapy through application in large animal model, development and optimization of the CARL Technology
2014


Certification of the company according to EN ISO 13485
2014


Clinical proof of concept in the context of an application observation at the The Medical Center – University of Freiburg
2016


Participation in the EU program “Horizon 2020, Fast Track to Innovation Pilot” for the project CIRDinnova. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 730527.
2017


The company is awarded the Freiburg Innovation Prize
2019


Move to larger company premises in the BioTechPark Freiburg
2020


CE approval of the system and start of the Post Market Clinical Follow-Up Study (PMCF) at four European centers
2021


Launch of the new brand identity
Establishment of the CARL Academy
Start of the FDA approval process and preparation for the US market entry
2022


Sales launch in Europe
Start of production and scale-up
Winning of the GDA and IF awards
2023


Certification according to regulation (EU) 2017/745
United for saving human lives.

Erich R. Reinhardt
Chairman of the Advisory Board

Thomas Kraft
Managing Director (CEO)

Christoph Benk
Managing Director (CTO)

Jörg Alexander Ronde
Managing Director (CFO)
Every life is unique, and every person is different.
Career.
The development of the system from the first draft to market maturity was and is closely linked to the personal competence, enthusiasm and cooperativeness of our founders and employees. We are particularly proud of the professional and personal skills of our employees and work to maintain the high quality of interdisciplinary cooperation in our company. To this end, it is necessary to assess the respective competencies and skills precisely and to link them in the interest of all involved without restricting the subjective scope of action too much.
What applies to the patient-specific use of the CARL System therefore also applies to the working conditions in our company: We offer our employees, students and trainees different career and training opportunities with working hours adapted to the situation, appropriate remuneration and numerous promotion opportunities.
As a future-oriented company, we also attach particular importance to a collegial and appreciative working environment in which a motivated team focuses not only on the economic goals of our company, but above all on the well-being, safety and quality standards of the people who are to benefit from our work. The following aspects of our corporate culture should contribute to this: respect, reliability and quality assurance.
Interested in a smart working environment?
Vacancies.
Interested? Then find out about our current vacancies, bachelor’s/master’s theses and internships and apply at careers@resuscitec.de
We are looking forward to hearing from you!